Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
UNITY Biotechnology, Inc. (UBX) had Return on Equity of -400.21% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-25.99M |
|
-- |
|
-- |
|
$31.17M |
|
$-31.17M |
|
$5.18M |
|
$-25.99M |
|
$-25.99M |
|
$-25.99M |
|
$-25.99M |
|
$-25.99M |
|
$-25.99M |
|
$-31.17M |
|
$-28.35M |
|
16.83M |
|
16.83M |
|
$-1.54 |
|
$-1.54 |
|
| Balance Sheet Financials | |
$24.27M |
|
$3.46M |
|
$13.39M |
|
$37.66M |
|
$9.26M |
|
-- |
|
$21.91M |
|
$31.17M |
|
$6.49M |
|
$6.49M |
|
$6.49M |
|
16.86M |
|
| Cash Flow Statement Financials | |
$-20.86M |
|
$8.56M |
|
$0.08M |
|
$20.70M |
|
$8.48M |
|
$-12.22M |
|
$3.97M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.84M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-400.21% |
-400.22% |
|
-69.01% |
|
-400.22% |
|
$0.39 |
|
$-1.24 |
|
$-1.24 |
|